In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cerecin Inc.

www.cerecin.com

Latest From Cerecin Inc.

Accera Sees New Potential As It Renames, Expands To Asia To Progress Alzheimer’s Asset

The US bioventure Accera, hit by a Phase III failure for its lead candidate last year, is expanding into Asia and renaming itself as it remains hopeful of progressing its core investigational asset in a targeted population of Alzheimer’s disease patients.

Singapore Business Strategies

Finance Watch: VC Tally Hits $14.5bn For 2018, Beating 2017 With A Quarter Left To Go

US VC investment in biopharma totaled $14.5bn in the first three quarters of 2018, exceeding the full-year 2017 sum of $11.9bn. UK biotech cash also is rising, benefitting new companies like Sitryx.
StartUps and SMEs Financing

A $63m VC Round Takes E-Scape Into Clinic With Alzheimer's, Parkinson's Drugs

E-Scape's Series A cash will fund the development of small molecules targeting genetic drivers of neurodegenerative diseases, such as ApoE4 in Alzheimer's disease. The venture capital financing with big pharma backing will be used to take two programs into the clinic.

Financing StartUps and SMEs

Deal Watch: Entasis, GARDP Partner On Novel Antibiotic For Drug-Resistant Gonorrhea

Servier and Transgene will collaborate to apply viral vector technology to the development of CAR-T therapeutics, while Chinese vaccine maker Sinovac is taken private by an investment consortium.

Deals M & A
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Accera Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Southeast Asia
        • Singapore
  • Parent & Subsidiaries
  • Cerecin Inc.
  • Senior Management
  • Charles Stacey, MD, Pres. & CEO
    Samuel Henderson, PhD, CSO
    Jerris Knaisch, VP, Fin. & North American Operations
    Cheryl Tan, BSc, VP, Commercial & Partnering
    Judy Walker, MD, CMO
  • Contact Info
  • Cerecin Inc.
    Phone: 6813 2999
    8 Shenton Way, #08-02
    AXA Tower
    , CO 06881
    Singapore
Advertisement
Advertisement
UsernamePublicRestriction

Register